Skip to content
2000
image of Integrative Rheumatology: A Holistic Approach to the Management of Systemic Lupus Erythematosus
file format pdf download PDF

Abstract

Background

Integrative medicine, which combines complementary and alternative medicine (CAM) with conventional treatments, is increasingly utilized by patients with systemic lupus erythematosus (SLE) to manage their condition.

Objective

This study aims to review the CAM available for SLE patients.

Methods

Studies focusing on CAM interventions in patients diagnosed with SLE were identified PubMed, Scopus, Cochrane Library, and Google Scholar through a systematic search conducted to identify relevant articles published up to May 2024.

Results

The potential therapeutic roles of specific micronutrients (vitamins A, C, D, and E), macronutrients (omega-3 fatty acids and probiotics), and supplements (ginger, turmeric) were examined, detailing their mechanisms and emerging evidence supporting their use. Additionally, the roles of dietary changes and mind-body interventions were discussed.

Conclusion

Despite the absence of established guidelines for supplementation and other interventions, this review emphasizes the need for personalized approaches tailored to individual characteristics and comorbidities. Healthcare providers are encouraged to enhance their knowledge of these CAM modalities to optimize patient care and improve overall quality of life for SLE patients.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/ccr/10.2174/0115733971389117250807101431
2025-08-15
2025-10-31

  • From This Site

    /content/journals/ccr/10.2174/0115733971389117250807101431
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/ccr/10.2174/0115733971389117250807101431/BMS-CRR-2025-15.html?itemId=/content/journals/ccr/10.2174/0115733971389117250807101431&mimeType=html&fmt=ahah

References

  1. Barnes P.M. Bloom B. Nahin R.L. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Rep. 2008 12 1 23 19361005
    [Google Scholar]
  2. Schmeding A. Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 2013 27 3 363 375 10.1016/j.berh.2013.07.009 24238693
    [Google Scholar]
  3. Pisetsky D.S. Clowse M.E.B. Criscione-Schreiber L.G. Rogers J.L. A novel system to categorize the symptoms of systemic lupus erythematosus. Arthritis Care Res. 2019 71 6 735 741 10.1002/acr.23794 30354033
    [Google Scholar]
  4. Greco C.M. Nakajima C. Manzi S. Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus. Curr. Rheumatol. Rep. 2013 15 11 378 10.1007/s11926‑013‑0378‑3 24078104
    [Google Scholar]
  5. Moore A.D. Petri M.A. Manzi S. Isenberg D.A. Gordon C. Senécal J.L. St Pierre Y. Joseph L. Penrod J. Fortin P.R. Sutcliffe N. Goulet J.R. Choquette D. Grodzicky T. Esdaile J.M. Clarke A.E. Trination Study Group The use of alternative medical therapies in patients with systemic lupus erythematosus. Arthritis Rheum. 2000 43 6 1410 1418 10.1002/1529‑0131(200006)43:6<1410::AID‑ANR27>3.0.CO;2‑U 10857802
    [Google Scholar]
  6. Alvarez-Nemegyei J. Bautista-Botello A. Dávila-Velázquez J. Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases. Clin. Rheumatol. 2009 28 5 547 551 10.1007/s10067‑008‑1082‑y 19139949
    [Google Scholar]
  7. Warner L.B.S. Utilization of complementary and integrative medicine among lupus patients: A patient centered analysis of perceived effectiveness and preference. Arthritis Rheumatol. 2018 70 9
    [Google Scholar]
  8. Handono K. Firdausi S.N. Pratama M.Z. Endharti A.T. Kalim H. Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus. Clin. Rheumatol. 2016 35 3 631 638 10.1007/s10067‑016‑3197‑x 26852315
    [Google Scholar]
  9. Miyabe Y. Miyabe C. Nanki T. Could retinoids be a potential treatment for rheumatic diseases? Rheumatol. Int. 2015 35 1 35 41 10.1007/s00296‑014‑3067‑2 24939557
    [Google Scholar]
  10. Yang J. Yang X. Zou H. Chu Y. Li M. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology 2011 50 8 1366 1372 10.1093/rheumatology/ker116 21489974
    [Google Scholar]
  11. Abdelhamid L. Alajoleen R. Kingsmore K.M. Cabana-Puig X. Lu R. Zhu J. Testerman J.C. Li Y. Ross A.C. Cecere T.E. Reilly C.M. Grammer A.C. Lipsky P.E. Luo X.M. Hypovitaminosis a drives the progression of tubulointerstitial lupus nephritis through potentiating predisease cellular autoreactivity. Immunohorizons 2023 7 1 17 29 10.4049/immunohorizons.2200015 36637518
    [Google Scholar]
  12. Kinoshita K. Kishimoto K. Shimazu H. Nozaki Y. Sugiyama M. Ikoma S. Funauchi M. Successful treatment with retinoids in patients with lupus nephritis. Am. J. Kidney Dis. 2010 55 2 344 347 10.1053/j.ajkd.2009.06.012 19628316
    [Google Scholar]
  13. Santiworakul C. Saisorn W. Siripen N. Leelahavanichkul A. Rianthavorn P. Interleukin-8 and neutrophil extracellular traps in children with lupus nephritis and vitamin C deficiency. Pediatr. Nephrol. 2024 39 4 1135 1142 10.1007/s00467‑023‑06189‑1 37889280
    [Google Scholar]
  14. Minami Y. Sasaki T. Arai Y. Kurisu Y. Hisamichi S. Diet and systemic lupus erythematosus: A 4 year prospective study of Japanese patients. J. Rheumatol. 2003 30 4 747 754 12672194
    [Google Scholar]
  15. Tam L.S. Li E.K. Leung V.Y. Griffith J.F. Benzie I.F. Lim P.L. Whitney B. Lee V.W. Lee K.K. Thomas G.N. Tomlinson B. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: A double blind, placebo controlled pilot study. J. Rheumatol. 2005 32 2 275 282 15693087
    [Google Scholar]
  16. Patavino T. Brady D.M. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern. Med. Rev. 2001 6 5 460 471 11703166
    [Google Scholar]
  17. Islam M.A. Khandker S.S. Kotyla P.J. Hassan R. Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (sle): A systematic review. Front. Immunol. 2020 11 1477 10.3389/fimmu.2020.01477 32793202
    [Google Scholar]
  18. Jiang L. Zhi S. Wei C. Rong Z. Zhang H. Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus. Front Pediatr. 2023 11 1252594 10.3389/fped.2023.1252594 38111622
    [Google Scholar]
  19. Zhang X. Guo Q. Sun S. Tang X. Shen W. Liang J. Yao G. Geng L. Ding S. Chen H. Wang H. Hua B. Wang D. Zhang H. Feng X. Sun L. Jin Z. Factors associated with 25-hydroxyvitamin D level in Chinese hospitalized patients with systemic lupus erythematosus: A retrospective cohort study. Rheumatol. Int. 2023 44 10 2067 2078 10.1007/s00296‑023‑05465‑5 37750894
    [Google Scholar]
  20. Kim J.W. Baek W.Y. Jung J.Y. Kim H.A. in Yang C. Kim S.J. Suh C.H. Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus. Eur. J. Clin. Invest. 2024 54 1 e14092 10.1111/eci.14092 37725441
    [Google Scholar]
  21. Zheng R. Gonzalez A. Yue J. Wu X. Qiu M. Gui L. Zhu S. Huang L. Efficacy and safety of vitamin d supplementation in patients with systemic lupus erythematosus: a meta-analysis of randomized controlled trials. Am. J. Med. Sci. 2019 358 2 104 114 10.1016/j.amjms.2019.04.020 31331447
    [Google Scholar]
  22. Wahono C.S. Susianti H. Hakim A.L. Rosita F. Pratama M.Z. Rahman P.A. Anshory M. Randomised clinical trial study: The combination of vitamin D and curcumin piperine attenuates disease activity and pro-inflammatory cytokines levels insystemic lupus erythematosus patients. Curr. Rheumatol. Rev. 2024 20 5 586 594 10.2174/0115733971276106231226071002 38299416
    [Google Scholar]
  23. Maeshima E. Liang X.M. Goda M. Otani H. Mune M. The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: A preliminary study. Clin. Rheumatol. 2007 26 3 401 404 10.1007/s10067‑006‑0477‑x 17143589
    [Google Scholar]
  24. Hsieh C.C. Lin B.F. The effects of vitamin E supplementation on autoimmune-prone New Zealand black × New Zealand white F1 mice fed an oxidised oil diet. Br. J. Nutr. 2005 93 5 655 662 10.1079/BJN20051413 15975164
    [Google Scholar]
  25. Hsieh C.C. Lin B.F. Opposite effects of low and high dose supplementation of vitamin E on survival of MRL/lpr mice. Nutrition 2005 21 9 940 948 10.1016/j.nut.2004.11.021 16054337
    [Google Scholar]
  26. Githaiga F.M. Omwenga G.I. Ngugi M.P. in vivo ameliorative effects of vitamin E against hydralazine-induced lupus. Lupus Sci. Med. 2023 10 2 e001033 10.1136/lupus‑2023‑001033 37989321
    [Google Scholar]
  27. Li X. Bi X. Wang S. Zhang Z. Li F. Zhao A.Z. Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases. Front. Immunol. 2019 10 2241 10.3389/fimmu.2019.02241 31611873
    [Google Scholar]
  28. Salek M. Hooshiar HS. Salek M. Poorebrahimi M. Jafarnejad S. Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus. Lupus 2023 32 1 7 22 10.1177/09612033221140724 36433776
    [Google Scholar]
  29. Moschetti L. Piantoni S. Vizzardi E. Sciatti E. Riccardi M. Franceschini F. Cavazzana I. Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: A common trigger for different microvascular diseases. Front. Med. 2022 9 849086 10.3389/fmed.2022.849086 35462989
    [Google Scholar]
  30. Curado Borges M. de Miranda Moura dos Santos F. Weiss Telles R. Melo de Andrade M.V. Correia TDM.I. Lanna C.C.D. Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: A pilot study. Rev. Bras. Reumatol. Engl. Ed. 2017 57 6 526 534 10.1016/j.rbre.2016.09.014 29173690
    [Google Scholar]
  31. Bello K.J. Fang H. Fazeli P. Bolad W. Corretti M. Magder L.S. Petri M. Omega-3 in SLE: A double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol. Int. 2013 33 11 2789 2796 10.1007/s00296‑013‑2811‑3 23817872
    [Google Scholar]
  32. Wright S.A. O’Prey F.M. McHenry M.T. Leahey W.J. Devine A.B. Duffy E.M. Johnston D.G. Finch M.B. Bell A.L. McVeigh G.E. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 2008 67 6 841 848 10.1136/ard.2007.077156 17875549
    [Google Scholar]
  33. Akbar U. Yang M. Kurian D. Mohan C. Omega-3 fatty acids in rheumatic diseases. J. Clin. Rheumatol. 2017 23 6 330 339 10.1097/RHU.0000000000000563 28816722
    [Google Scholar]
  34. Mu Q. Zhang H. Luo X.M. SLE: Another autoimmune disorder influenced by microbes and diet? Front. Immunol. 2015 6 608 10.3389/fimmu.2015.00608 26648937
    [Google Scholar]
  35. Vojdani A. Gushgari L.R. Vojdani E. Interaction between food antigens and the immune system: Association with autoimmune disorders. Autoimmun. Rev. 2020 19 3 102459 10.1016/j.autrev.2020.102459 31917265
    [Google Scholar]
  36. Silverman G.J. Azzouz D.F. Gisch N. Amarnani A. The gut microbiome in systemic lupus erythematosus: Lessons from rheumatic fever. Nat. Rev. Rheumatol. 2024 20 3 143 157 10.1038/s41584‑023‑01071‑8 38321297
    [Google Scholar]
  37. Charoensappakit A. Sae-khow K. Leelahavanichkul A. Gut barrier damage and gut translocation of pathogen molecules in lupus, an impact of innate immunity (macrophages and neutrophils) in autoimmune disease. Int. J. Mol. Sci. 2022 23 15 8223 10.3390/ijms23158223 35897790
    [Google Scholar]
  38. Yao K. Xie Y. Wang J. Lin Y. Chen X. Zhou T. Gut microbiota: A newly identified environmental factor in systemic lupus erythematosus. Front. Immunol. 2023 14 1202850 10.3389/fimmu.2023.1202850 37533870
    [Google Scholar]
  39. Widhani A. Djauzi S. Suyatna F.D. Dewi B.E. Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells 2022 11 21 3419 10.3390/cells11213419 36359816
    [Google Scholar]
  40. Guo X. Yang X. Li Q. Shen X. Zhong H. Yang Y. The microbiota in systemic lupus erythematosus: An update on the potential function of probiotics. Front. Pharmacol. 2021 12 759095 10.3389/fphar.2021.759095 34887760
    [Google Scholar]
  41. Huang C. Yi P. Zhu M. Zhou W. Zhang B. Yi X. Long H. Zhang G. Wu H. Tsokos G.C. Zhao M. Lu Q. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An explorer trial. J. Autoimmun. 2022 130 102844 10.1016/j.jaut.2022.102844 35690527
    [Google Scholar]
  42. Lai Z.W. Hanczko R. Bonilla E. Caza T.N. Clair B. Bartos A. Miklossy G. Jimah J. Doherty E. Tily H. Francis L. Garcia R. Dawood M. Yu J. Ramos I. Coman I. Faraone S.V. Phillips P.E. Perl A. N -acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012 64 9 2937 2946 10.1002/art.34502 22549432
    [Google Scholar]
  43. Garcia R.J. Francis L. Dawood M. Lai Z.W. Faraone S.V. Perl A. Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum. 2013 65 5 1313 1318 10.1002/art.37893 23400548
    [Google Scholar]
  44. Abbasifard M. Khorramdelazad H. Rostamian A. Rezaian M. Askari P.S. Sharifi G.T.K. Parizi M.K. Sharifi M.T.K. Najafizadeh S.R. Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: A randomized double-blind clinical trial study. Trials 2023 24 1 129 10.1186/s13063‑023‑07083‑9 36810107
    [Google Scholar]
  45. Tewthanom K. Janwitayanujit S. Totemchockcyakarn K. Panomvana Na Ayudhya D. The effect of high dose of N -acetylcysteine in lupus nephritis: A case report and literature review. J. Clin. Pharm. Ther. 2009 35 4 483 485 10.1111/j.1365‑2710.2009.01108.x 20831550
    [Google Scholar]
  46. Li M. Gao W. Ma J. Zhu Y. Li X. Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases. Exp. Ther. Med. 2015 10 2 689 692 10.3892/etm.2015.2510 26622376
    [Google Scholar]
  47. Nasr S. Perl A. Principles behind SLE treatment with N-acetylcysteine. Immunometabolism 2022 4 4 e00010 10.1097/IN9.0000000000000010 36312742
    [Google Scholar]
  48. Ballester P. Cerdá B. Arcusa R. Marhuenda J. Yamedjeu K. Zafrilla P. Effect of ginger on inflammatory diseases. Molecules 2022 27 21 7223 10.3390/molecules27217223 36364048
    [Google Scholar]
  49. Ali R.A. Gandhi A.A. Dai L. Weiner J. Estes S.K. Yalavarthi S. Gockman K. Sun D. Knight J.S. Antineutrophil properties of natural gingerols in models of lupus. JCI Insight 2021 6 3 e138385 10.1172/jci.insight.138385 33373329
    [Google Scholar]
  50. Ali R.A. Minarchick V.C. Zahavi M. Rysenga C.E. Sturm K.A. Hoy C.K. Sarosh C. Knight J.S. Demoruelle M.K. Ginger intake suppresses neutrophil extracellular trap formation in autoimmune mice and healthy humans. JCI Insight 2023 8 18 e172011 10.1172/jci.insight.172011 37737262
    [Google Scholar]
  51. Chamani S. Moossavi M. Naghizadeh A. Abbasifard M. Majeed M. Johnston T.P. Sahebkar A. Immunomodulatory effects of curcumin in systemic autoimmune diseases. Phytother. Res. 2022 36 4 1616 1632 10.1002/ptr.7417 35302258
    [Google Scholar]
  52. Ramessar N. Borad A. Schlesinger N. The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review. Lupus 2023 32 5 644 657 10.1177/09612033231161961 36867423
    [Google Scholar]
  53. Zhao J. Wang J. Zhou M. Li M. Li M. Tan H. Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome. Int. Immunopharmacol. 2019 69 213 216 10.1016/j.intimp.2019.01.046 30738291
    [Google Scholar]
  54. Li Q. Tan S. Xu K. Fu X. Yu J. Yang H. Wang H. Curcumin attenuates lupus nephritis in MRL/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF). Int. J. Clin. Exp. Pathol. 2019 12 6 2075 2083 31934029
    [Google Scholar]
  55. Momtazi-Borojeni A.A. Haftcheshmeh S.M. Esmaeili S.A. Johnston T.P. Abdollahi E. Sahebkar A. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun. Rev. 2018 17 2 125 135 10.1016/j.autrev.2017.11.016 29180127
    [Google Scholar]
  56. Khajehdehi P. Zanjaninejad B. Aflaki E. Nazarinia M. Azad F. Malekmakan L. Dehghanzadeh G.R. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. J. Ren. Nutr. 2012 22 1 50 57 10.1053/j.jrn.2011.03.002 21742514
    [Google Scholar]
  57. Singgih Wahono C. Diah Setyorini C. Kalim H. Nurdiana N. Handono K. Effect of Curcuma xanthorrhiza supplementation on systemic lupus erythematosus patients with hypovitamin D which were given vitamin D 3 towards disease activity (SLEDAI), IL-6, and TGF- β 1 Serum. Int. J. Rheumatol. 2017 2017 1 8 10.1155/2017/7687053 29445400
    [Google Scholar]
  58. Setiawati M.C. Ikawati Z. Kertia I.N. Antiinflamatory and antidepressive activities of extract curcuma xanthorrhiza roxb in systemic lupus erythematosus. Indones. J. Pharm. 2017 28 3 185 10.14499/indonesianjpharm28iss3pp185
    [Google Scholar]
  59. Constantin M.M. Nita I. Olteanu R. Constantin T. Bucur S. Matei C. Raducan A. Significance and impact of dietary factors on systemic lupus erythematosus pathogenesis (Review). Exp. Ther. Med. 2018 17 2 1085 1090 10.3892/etm.2018.6986 30679978
    [Google Scholar]
  60. Knippenberg A. Robinson G.A. Wincup C. Ciurtin C. Jury E.C. Kalea A.Z. Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus. Lupus 2022 31 1 65 76 10.1177/09612033211063795 34978516
    [Google Scholar]
  61. Goldner B. Staffier K.L. Case series: Raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sjögren’s syndrome. Front. Nutr. 2024 11 1208074 10.3389/fnut.2024.1208074 38505266
    [Google Scholar]
  62. Pocovi-Gerardino G. Correa-Rodríguez M. Callejas-Rubio J.L. Ríos-Fernández R. Martín-Amada M. Cruz-Caparros M.G. Rueda-Medina B. Ortego-Centeno N. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: A cross-sectional study. Rheumatology 2021 60 1 160 169 10.1093/rheumatology/keaa210 32594173
    [Google Scholar]
  63. Zhang X. Meng J. Shi X. Quinet R.J. Davis W. Zakem J. Keshavamurthy C. Patel R. Lobo G. Hellmers L. Ray A.N. Rivers L.E. Ali H. Posas-Mendoza T. Hille C. You Z. Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr mice. Lupus Sci. Med. 2023 10 1 e000898 10.1136/lupus‑2023‑000898 37041033
    [Google Scholar]
  64. Frade S. O’Neill S. Greene D. Cameron M. Exercise as adjunctive therapy for systemic lupus erythematosus. Cochrane Libr. 2021 2021 10 10.1002/14651858.CD014816 37073886
    [Google Scholar]
  65. Middleton K.R. Moonaz HS. Hasni S.A. Magaña López M. Tataw-Ayuketah G. Farmer N. Wallen G.R. Yoga for systemic lupus erythematosus (SLE): Clinician experiences and qualitative perspectives from students and yoga instructors living with SLE. Complement. Ther. Med. 2018 41 111 117 10.1016/j.ctim.2018.09.001 30477826
    [Google Scholar]
  66. Moonaz S.H. Bingham C.O. III Wissow L. Bartlett S.J. Yoga in sedentary adults with arthritis: Effects of a randomized controlled pragmatic trial. J. Rheumatol. 2015 42 7 1194 1202 10.3899/jrheum.141129 25834206
    [Google Scholar]
  67. Lee M.S. Pittler M.H. Ernst E. Tai chi for rheumatoid arthritis: Systematic review. Rheumatology 2007 46 11 1648 1651 10.1093/rheumatology/kem151 17634188
    [Google Scholar]
  68. Han A. Judd M. Welch V. Wu T. Tugwell P. Wells G.A. Tai chi for treating rheumatoid arthritis. Cochrane Libr. 2004 3 CD004849 10.1002/14651858.CD004849 15266544
    [Google Scholar]
  69. Yedimenko J TE Snoad B Sharma J Mobeen M Steigelman H Meara A Valiente GR Ardoin SP Powell N Sheridan J Jarjour W Young NA The effects of Tai Chi on inflammatory mediator secretion in systemic lupus erythematosus. Arthritis Rheumatol 2017 69 10
    [Google Scholar]
  70. O’Dwyer T. Durcan L. Wilson F. Exercise and physical activity in systemic lupus erythematosus: A systematic review with meta-analyses. Semin. Arthritis Rheum. 2017 47 2 204 215 10.1016/j.semarthrit.2017.04.003 28477898
    [Google Scholar]
  71. Parodis I. Girard-Guyonvarc’h C. Arnaud L. Distler O. Domján A. Van den Ende C.H.M. Fligelstone K. Kocher A. Larosa M. Lau M. Mitropoulos A. Ndosi M. Poole J.L. Redmond A. Ritschl V. Alexanderson H. Sjöberg Y. von Perner G. Uhlig T. Varju C. Vriezekolk J.E. Welin E. Westhovens R. Stamm T.A. Boström C. Eular recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann. Rheum. Dis. 2024 83 6 720 729 10.1136/ard‑2023‑224416 37433575
    [Google Scholar]
  72. Wang H. Wang B. Huang J. Yang Z. Song Z. Zhu Q. Xie Z. Sun Q. Zhao T. Efficacy and safety of acupuncture therapy combined with conventional pharmacotherapy in the treatment of systemic lupus erythematosus: A systematic review and meta-analysis. Medicine 2023 102 40 e35418 10.1097/MD.0000000000035418 37800775
    [Google Scholar]
  73. Nahin R.L. Barnes P.M. Stussman B.J. Insurance coverage for complementary health approaches among adult users: United States, 2002 and 2012. NCHS Data Brief 2016 235 1 8 26828643
    [Google Scholar]
  74. Niazi A. Niazi S. Mindfulness-based stress reduction: A non-pharmacological approach for chronic illnesses. N. Am. J. Med. Sci. 2011 3 1 20 23 10.4297/najms.2011.320 22540058
    [Google Scholar]
  75. Taub R. Horesh D. Rubin N. Glick I. Reem O. Shriqui G. Agmon-Levin N. Mindfulness-based stress reduction for systemic lupus erythematosus: A mixed-methods pilot randomized controlled trial of an adapted protocol. J. Clin. Med. 2021 10 19 4450 10.3390/jcm10194450 34640468
    [Google Scholar]
  76. Horesh D. Glick I. Taub R. Agmon-Levin N. Shoenfeld Y. Mindfulness-based group therapy for systemic lupus erythematosus: A first exploration of a promising mind-body intervention. Complement. Ther. Clin. Pract. 2017 26 73 75 10.1016/j.ctcp.2016.11.011 28107854
    [Google Scholar]
/content/journals/ccr/10.2174/0115733971389117250807101431
Loading
Integrative Rheumatology: A Holistic Approach to the Management of Systemic Lupus Erythematosus
Bentham Science Publishers ; https://doi.org/10.2174/0115733971389117250807101431
/content/journals/ccr/10.2174/0115733971389117250807101431
/content/journals/ccr/10.2174/0115733971389117250807101431
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: integrative medicine ; Systemic lupus erythematosus ; complementary medicine ; arthritis, QOL ; alternative medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test